A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma

Nanoparticle delivery systems have been shown to improve the therapeutic efficacy of anti-cancer drugs, including a variety of drugs for the treatment of hepatocellular carcinoma (HCC). However, the current systems show some limitations, and the delivery of more effective nanoparticle systems for an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ming-Hua, Fu, Zai-Lin, Hua, Ai-Lian, Zhou, Ji-Fang, Chen, Qian, Li, Jian-Bo, Yao, Shen, Cai, Xin-Jun, Ge, Min, Zhou, Li, Wu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515951/
https://www.ncbi.nlm.nih.gov/pubmed/36185205
http://dx.doi.org/10.3389/fonc.2022.932156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515951/
https://www.ncbi.nlm.nih.gov/pubmed/36185205
http://dx.doi.org/10.3389/fonc.2022.932156

Ejemplares similares